Search Results - "Ochs, Rachel"

Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post‐essential thrombocythemia myelofibrosis: A case report by Cheekati, Mahija, Siu, KarLeung, Ochs, Rachel

“…Paroxysmal nocturnal hemoglobinuria (PNH) results from the loss of erythrocyte surface proteins, leading to complement activation and its spectrum of effects…”
Get full text

Genome-wide association study and polygenic risk score analysis of esketamine treatment response by Li, Qingqin S., Wajs, Ewa, Ochs-Ross, Rachel, Singh, Jaskaran, Drevets, Wayne C.

“…To elucidate the genetic underpinnings of the antidepressant efficacy of S-ketamine (esketamine) nasal spray in major depressive disorder (MDD), we performed a…”
Get full text

Molecular genetic characterization of lymphoma: Application to cytology diagnosis by Ochs, Rachel C., Bagg, Adam

“…Mature B‐ and T‐cell lymphomas are increasingly being associated with specific genetic alterations; characterization of these changes can sometimes be crucial…”
Get full text

Isolated bowel relapse in acute promyelocytic leukemia: an unusual site of extramedullary recurrence by Ochs, Rachel C, Gormley, Rachel H, Luger, Selina, Bagg, Adam

Get full text

Risk Factors for Interstitial Cystitis in the General Population and in Individuals With Depression by Cepeda, M Soledad, Reps, Jenna, Sena, Anthony G, Ochs-Ross, Rachel

“…To identify risk factors for interstitial cystitis (IC), a chronic bladder disorder that may have a significant detrimental impact on quality of life, in the…”
Get full text

A randomized, multicenter, crossover psychometric evaluation study of an iPad-administered cognitive test battery in participants with major depressive disorder who responded to treatment with oral antidepressants by Bogert, Jennifer, Rofael, Hany, Mosca, Kenneth, Ross, Rachel Ochs, Callaerts, Geert, Wang, Daniel, Jaeger, Judith, Narayan, Vaibhav A., Drevets, Wayne C., Morrison, Randall L.

“…•Cognitive impairment in MDD impedes functional recovery.•ReVeRe.D, an iPad-administered cognitive test battery is developed for MDD.•ReVeRe.D tests showed…”
Get full text

Quadruple Hit Lymphoma: A Rare Entity with Dismal Prognosis by Proulx, Jonathan, Denley, Ryan, Pedemonte, Bader Maria, Shah, Ashish A., Ochs, Rachel, Haigentz, Missak, Alistar, Angela T., Early, Ellen, Whitman, Eric D, Cherry, Mohamad

“…Introduction The WHO 2016 classification for hematologic malignancies has introduced a new entity: High-grade B cell lymphomas (HGBL), with MYC and BCL2 and/or…”
Get full text

De novo acute myeloid leukemia with 20–29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study by Hasserjian, Robert Paul, Campigotto, Federico, Klepeis, Veronica, Fu, Bin, Wang, Sa A., Bueso‐Ramos, Carlos, Cascio, Michael Joseph, Rogers, Heesun Joyce, Hsi, Eric Darryl, Soderquist, Craig, Bagg, Adam, Yan, Jiong, Ochs, Rachel, Orazi, Attilio, Moore, Frank, Mahmoud, Amer, George, Tracy Irene, Foucar, Kathryn, Odem, Jamie, Booth, Cassie, Morice, William, DeAngelo, Daniel J., Steensma, David, Stone, Richard Maury, Neuberg, Donna, Arber, Daniel Alan

“…It is controversial whether acute myeloid leukemia (AML) patients with 20–29% bone marrow (BM) blasts, formerly referred to as refractory anemia with excess…”
Get full text

Does head-turning during a seizure have lateralizing or localizing significance? by OCHS, R, GLOOR, P, QUESNEY, F, IVES, J, OLIVIER, A

“…Forced lateralized head-turning, occurring as the first clinical sign in 106 epileptic seizures in 43 patients, was recorded on videotape simultaneously with…”
Get full text

Autism: Comorbidities and Treatment Patterns in the Real World, a Retrospective Cohort Study Among Children, Adolescents and Adults Newly Diagnosed with Autism by Shoaib, Azza, Cepeda, M. Soledad, Murray, Gayle, Ochs-Ross, Rachel

“…We used real world data to summarize comorbidities and interventions among patients newly diagnosed with autism spectrum disorder (ASD). Data were derived from…”
Get full text

Post-immunosuppressive and immunomodulatory therapy lymphoproliferative disorders of the gastrointestinal tract by Ochs, Rachel, Stashek, Kristen M

“…Abstract Post-immunosuppressive and immunomodulatory therapy lymphoproliferative disorders occur during immunosuppressive treatment following allogeneic solid…”
Get full text

Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression—TRANSFORM-3 by Ochs-Ross, Rachel, Daly, Ella J., Zhang, Yun, Lane, Rosanne, Lim, Pilar, Morrison, Randall L., Hough, David, Manji, Husseini, Drevets, Wayne C., Sanacora, Gerard, Steffens, David C., Adler, Caleb, McShane, Rupert, Gaillard, Raphaël, Wilkinson, Samuel T., Singh, Jaskaran B.

“…•What is the primary question addressed by this study?This first-in-kind randomized, double-blind, active-controlled trial for treatment-resistant depression…”
Get full text

Comparison of air-fluidized therapy with other support surfaces used to treat pressure ulcers in nursing home residents by Ochs, Rachel F, Horn, Susan D, van Rijswijk, Lia, Pietsch, Catherine, Smout, Randall J

“…To provide empirical evidence comparing pressure ulcer healing rates between different support surfaces, data were analyzed from eligible residents with…”
Get full text

Refractory Anemia With Excess Blasts In Transformation (Acute Myeloid Leukemia with 20-29% Blasts) in Older Adults is Less Aggressive Than Acute Myeloid Leukemia With ≥30% Blasts by Hasserjian, Robert P, Campigotto, Federico, Klepeis, Veronica, Fu, Bin, Wang, Sa A., Cascio, Michael J, Rogers, Heesun J., Hsi, Eric D., Soderquist, Craig, Bagg, Adam, Yang, Jiong, Ochs, Rachel C, Orazi, Attilio, Foucar, Kathryn, Moore, Frank, Mahmoud, Amer, George, Tracy I., DeAngelo, Daniel J, Steensma, David P., Stone, Richard M., Neuberg, Donna S., Arber, Daniel A.

“…The current WHO Classification defines acute myeloid leukemia (AML) in most cases as a myeloid neoplasm with ≥20% bone marrow (BM) or peripheral blood (PB)…”
Get full text

De novo acute myeloid leukemia with 20–29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a B one M arrow P athology G roup study by Hasserjian, Robert Paul, Campigotto, Federico, Klepeis, Veronica, Fu, Bin, Wang, Sa A., Bueso‐Ramos, Carlos, Cascio, Michael Joseph, Rogers, Heesun Joyce, Hsi, Eric Darryl, Soderquist, Craig, Bagg, Adam, Yan, Jiong, Ochs, Rachel, Orazi, Attilio, Moore, Frank, Mahmoud, Amer, George, Tracy Irene, Foucar, Kathryn, Odem, Jamie, Booth, Cassie, Morice, William, DeAngelo, Daniel J., Steensma, David, Stone, Richard Maury, Neuberg, Donna, Arber, Daniel Alan

“…It is controversial whether acute myeloid leukemia (AML) patients with 20–29% bone marrow (BM) blasts, formerly referred to as refractory anemia with excess…”
Get full text

Primary and secondary drug screening assays for Friedreich ataxia by Cotticelli, M Grazia, Rasmussen, Lynn, Kushner, Nicole L, McKellip, Sara, Sosa, Melinda Ingrum, Manouvakhova, Anna, Feng, Shuang, White, E Lucile, Maddry, Joseph A, Heemskerk, Jill, Oldt, Robert J, Surrey, Lea F, Ochs, Rachel, Wilson, Robert B

“…Friedreich ataxia (FRDA) is an autosomal recessive neuro- and cardiodegenerative disorder for which there are no proven effective treatments. FRDA is caused by…”
Get more information

6.11 Clinician and Parent Reporting of Autism Spectrum Disorder Behaviors: Development of a Clinician Version of the Autism Behavior Inventory by Bangerter, Abigail, Halter, Robin, Meyer, Martine, Trudeau, Jeremiah, Ochs-Ross, Rachel, Aman, Michael, Hendren, Robert, Leventhal, Bennett, Pandina, Gahan

Get full text

Effect of Esketamine Nasal Spray on Cognition in Patients With Treatment-Resistant Depression: Results From Four Phase 3 Studies by Morrison, Randall L, Singh, Jaskaran, Daly, Ella, Fedgchin, Maggie, Ochs-Ross, Rachel, Karcher, Keith, Lane, Rosanne, Cooper, Kim, Sanacora, Gerard, Maruff, Paul, Drevets, Wayne C

“…Abstract Background While esketamine is effective in treatment-resistant depression (TRD), detailed information about the effect of esketamine on cognition is…”
Get full text

Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post-essential thrombocythemia myelofibrosis: A case report by Cheekati, Mahija, Siu, KarLeung, Ochs, Rachel

“…Paroxysmal nocturnal hemoglobinuria (PNH) results from the loss of erythrocyte surface proteins, leading to complement activation and its spectrum of effects…”
Get full text

Comparison of Long-Term Efficacy and Safety of Esketamine Nasal Spray Plus Oral Antidepressant in Younger Versus Older Patients With Treatment-Resistant Depression: Post-Hoc Analysis of SUSTAIN-2, a Long-Term Open-Label Phase 3 Safety and Efficacy Study by Ochs-Ross, Rachel, Wajs, Ewa, Daly, Ella J., Zhang, Yun, Lane, Rosanne, Lim, Pilar, Drevets, Wayne C., Steffens, David C., Sanacora, Gerard, Jamieson, Carol, Hough, David, Manji, Husseini, Singh, Jaskaran B.

“…•What is the primary question addressed by this study?Is there a difference in the response and safety profile of esketamine nasal spray treatment in younger…”
Get full text